Clinical Trial Update: HP011-101, HP828-101, and Standard Care for Pressure Ulcers [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating HP011-101 and HP828-101 for pressure ulcers has been withdrawn from ClinicalTrials.gov.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressure Ulcers

Drugs mentioned

• HP011-101
• HP828-101

Snippet

Sponsor: Healthpoint | Conditions: Pressure Ulcers | Phase 2 | Status: WITHDRAWN